Division of Hospital Medicine, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
University of Missouri, Kansas City, Kansas City, Missouri.
Hosp Pediatr. 2022 Jun 1;12(6):569-577. doi: 10.1542/hpeds.2021-006417.
Sources of variation within febrile infant management are incompletely described. In 2016, a national standardization quality improvement initiative, Reducing Excessive Variation in Infant Sepsis Evaluations (REVISE) was implemented. We sought to: (1) describe sociodemographic factors influencing laboratory obtainment and hospitalization among febrile infants and (2) examine the association of REVISE on any identified sources of practice variation.
We included febrile infants ≤60 days of age evaluated between December 1, 2015 and November 30, 2018 at Pediatric Health Information System-reporting hospitals. Patient demographics and hospital characteristics, including participation in REVISE, were identified. Factors associated with variation in febrile infant management were described in relation to the timing of the REVISE initiative.
We identified 32 572 febrile infants in our study period. Pre-REVISE, payer-type was associated with variation in laboratory obtainment and hospitalization. Compared with those with private insurance, infants with self-pay (adjusted odds ratio [aOR] 0.43, 95% confidence interval [95% CI] 0.22-0.5) or government insurance (aOR 0.67, 95% CI 0.60-0.75) had lower odds of receiving laboratories, and self-pay infants had lower odds of hospitalization (aOR 0.38, 95% CI 0.28-0.51). Post-REVISE, payer-related disparities in care remained. Disparities in care were not associated with REVISE participation, as the interaction of time and payer was not statistically different between non-REVISE and REVISE centers for either laboratory obtainment (P = .09) or hospitalization (P = .67).
Payer-related care inequalities exist for febrile infants. Patterns in disparities were similar over time for both non-REVISE and REVISE-participating hospitals. Further work is needed to better understand the role of standardization projects in reducing health disparities.
发热婴儿管理中的变异来源描述不完整。2016 年,实施了一项国家标准化质量改进倡议,即减少婴儿脓毒症评估中的过度变异(REVISE)。我们旨在:(1)描述影响发热婴儿实验室获取和住院的社会人口学因素;(2)研究 REVISE 对任何已确定的实践变异来源的关联。
我们纳入了 2015 年 12 月 1 日至 2018 年 11 月 30 日期间在儿科健康信息系统报告医院就诊的≤60 天龄发热婴儿。确定了患者人口统计学和医院特征,包括参与 REVISE 的情况。根据 REVISE 倡议的时间,描述了发热婴儿管理中的变异因素。
在研究期间,我们确定了 32572 例发热婴儿。在 REVISE 之前,付款人类型与实验室获取和住院治疗的变异有关。与有私人保险的婴儿相比,自付(调整后的优势比 [aOR] 0.43,95%置信区间 [95%CI] 0.22-0.5)或政府保险(aOR 0.67,95%CI 0.60-0.75)的婴儿获得实验室检测的可能性较低,自付婴儿住院的可能性较低(aOR 0.38,95%CI 0.28-0.51)。REVISE 之后,护理方面仍然存在与付款人相关的差异。护理方面的差异与 REVISE 的参与无关,因为在非 REVISE 和 REVISE 中心之间,时间和付款人之间的相互作用在实验室获取(P=0.09)或住院治疗(P=0.67)方面没有统计学差异。
发热婴儿存在与付款人相关的护理不平等现象。对于非 REVISE 和参与 REVISE 的医院,随着时间的推移,差异模式相似。需要进一步研究以更好地了解标准化项目在减少健康差异方面的作用。